Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Maki, D. Maki, C. Alvarado, M. Ringer (1991)
Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial cathetersThe Lancet, 338
Merrer Merrer, De Jonghe De Jonghe, Golliot Golliot, Lefrant Lefrant, Raffy Raffy, Barre Barre, Rigaud Rigaud, Casciani Casciani, Misset Misset, Bosquet Bosquet, Outin Outin, Brun‐Buisson Brun‐Buisson, Nitenberg Nitenberg (2001)
Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trialJournal of the American Medical Association, 286
Collin Collin (1999)
Decreasing catheter colonization through the use of an antiseptic‐impregnated catheter: a continuous quality improvement projectChest, 115
S. Heard, M. Wagle, E. Vijayakumar, E. Vijayakumar, S. McLean, A. Brueggemann, L. Napolitano, L. Napolitano, L. Edwards, L. Edwards, F. O'Connell, J. Puyana, G. Doern (1998)
Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.Archives of internal medicine, 158 1
P. Arnow, E. Quimosing, M. Beach (1994)
Consequences of intravascular catheter sepsisAmerican Journal of Infection Control, 22
K. Jaeger, S. Zenz, B. Jüttner, H. Ruschulte, E. Kuse, J. Heine, S. Piepenbrock, A. Ganser, M. Karthaus (2005)
Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheterAnnals of Hematology, 84
R. Mallya (2003)
Prevention of Central Venous Catheter-related Infections, 5
Merrer (2001)
700Journal of the American Medical Association, 286
Brent Richards, Wendy Chaboyer, T. Bladen, P. Schluter (2003)
Effect of central venous catheter type on infections: a prospective clinical trial.The Journal of hospital infection, 54 1
D. Maki, Susanne Stolz, Susan Wheeler, L. Mermel (1997)
Prevention of Central Venous Catheter-Related Bloodstream Infection by Use of an Antiseptic-Impregnated CatheterAnnals of Internal Medicine, 127
Shane George, P. Vuddamalay, M. Boscoe (1997)
Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients.European journal of anaesthesiology, 14 4
Arnow (1993)
778Clinical Infectious Diseases, 16
D. McGee, M. Gould (2003)
Preventing complications of central venous catheterization.The New England journal of medicine, 348 12
Raad Raad, Darouiche Darouiche, Dupuis Dupuis, Abi‐Said Abi‐Said, Gabrielli Gabrielli, Hachem Hachem, Wall Wall, Harris Harris, Jones Jones, Buzaid Buzaid, Robertson Robertson, Shenaq Shenaq, Curling Curling, Burke Burke, Ericsson Ericsson, Study Study (1997)
Central venous catheters coated with minocycline and rifampicin for the prevention of catheter‐related colonization and bloodstream infections: a randomized, double‐blind trialAnnals of Internal Medicine, 127
D. Pittet, D. Tarara, R. Wenzel (1994)
Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.JAMA, 271 20
Richards Richards, Edwards Edwards, Culver Culver, Gaynes Gaynes (1999)
Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 27
G. Collin (1999)
Clinical Investigations in Critical CareDecreasing Catheter Colonization Through the Use of an Antiseptic-Impregnated Catheter: A Continuous Quality Improvement ProjectChest, 115
E. Tacconelli, M. Tumbarello, M. Pittiruti, F. Leone, M. Lucia, R. Cauda, L. Ortona (1997)
Central venous catheter-related sepsis in a cohort of 366 hospitalised patientsEuropean Journal of Clinical Microbiology and Infectious Diseases, 16
(2006)
Infectious complications in haematological patients with central venous catheters : a prospective analysis of risk factors and etiological agents
Maki Maki, Stolz Stolz, Wheeler Wheeler, Mermel Mermel (1997)
Prevention of central venous catheter‐related bloodstream infection by use of an antiseptic‐impregnated catheter: a randomized, controlled trialAnnals of Internal Medicine, 127
O. Traoré, J. Liotier, B. Souweine (2005)
Prospective study of arterial and central venous catheter colonization and of arterial- and central venous catheter–related bacteremia in intensive care units*Critical Care Medicine, 33
I. Raad, R. Darouiche, J. Dupuis, D. Abi‐Said, A. Gabrielli, R. Hachem, M. Wall, R. Harris, James Jones, A. Buzaid, C. Robertson, S. Shenaq, P. Curling, T. Burke, C. Ericsson (1997)
Central Venous Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter-Related Colonization and Bloodstream InfectionsAnnals of Internal Medicine, 127
M. Richards, J. Edwards, D. Culver, R. Gaynes (1999)
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.Critical care medicine, 27 5
T. Ostendorf, Andrea Meinhold, C. Harter, H. Salwender, G. Egerer, H. Geiss, A. Ho, H. Goldschmidt (2005)
Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients—a double-blind, randomised, prospective, controlled trialSupportive Care in Cancer, 13
Martina niChonghaile (2002)
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients: A Randomized Controlled TrialSurvey of Anesthesiology, 46
David Veenstra, S. Saint, Somnath Saha, T. Lumley, Sean Sullivan (1999)
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.JAMA, 281 3
Pittet (1994)
1598Journal of the American Medical Association, 271
Arnow Arnow, Quimosing Quimosing, Beach Beach (1993)
Consequences of intravascular catheter sepsisClinical Infectious Diseases, 16
S. Gnass, L. Barboza, Dafne Bilicich, P. Angeloro, Walter Treiyer, S. Grenóvero, J. Basualdo (2004)
Prevention of central venous catheter-related bloodstream infections using non-technologic strategies.Infection control and hospital epidemiology, 25 8
I. Raad, David Hohn, B. Gilbreath, N. Suleiman, Lou Hill, Patricia Bruso, K. Marts, Paul Mansfield, Gerald Bodey (1994)
Prevention of Central Venous Catheter-Related Infections by Using Maximal Sterile Barrier Precautions During InsertionInfection Control & Hospital Epidemiology, 15
Ciresi (1996)
641American Surgeon, 62
George (1997)
428European Journal of Anaesthesiology, 14
Maki (1991)
329Lancet, 328
A. Bach, H. Schmidt, Bernd Böttiger, B. Schreiber, H. Böhrer, J. Motsch, E. Martin, H.-G. Sonntag (1996)
Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters.The Journal of antimicrobial chemotherapy, 37 2
O. Mimoz, L. Pieroni, C. Lawrence, A. Edouard, Y. Costa, K. Samii, C. Brun-Buisson (1996)
Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.Critical care medicine, 24 11
D. Ciresi, R. Albrecht, P. Volkers, D. Scholten (1996)
Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.The American surgeon, 62 8
Immuno‐compromised patients are at high risk for all kind of infections. Unfortunately, they need central venous catheters (CVCs), which are associated with infectious complications. In this study we examined the effectiveness of chlorhexidine‐silver sulfadiazine impregnated CVCs to prevent catheter‐related infections in patients receiving high‐dose chemotherapy followed by peripheral stem cell transplantation. This historical cohort study evaluated 139 patients of whom 70 patients were provided with non‐impregnated CVCs and 69 patients with impregnated CVCs. Patients were treated for different diagnoses. The median number of days a CVC stayed in situ was 18 in the non‐impregnated group and 16 in the impregnated group. The median duration of neutropenia of patients with non‐impregnated CVCs was 9 days compared with 7 days of patients with impregnated CVCs. We found less catheter colonization (CC) in patients with chlorhexidine‐silver sulfadiazine CVCs (RR 0.63, 95% CI 0.41–0.96; P = 0.03). Catheter‐related blood stream infections (CR‐BSI) were also diminished, but this result was not statistically significant (RR 0.15, 95% CI 0.02–1.15; P = 0.06). The reduction in CC and CR‐BSI did not diminish the incidence of fever. We conclude that the use of chlorhexidine–silver sulfadiazine impregnated CVCs provide an important improvement in the attempt to reduce CC and CR‐BSI.
European Journal of Cancer Care – Wiley
Published: Sep 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.